| MolName | (5Z)-3-(furan-2-ylmethyl)-5-[[2-[(2-hydroxy-2-phenylethyl)amino]-4-oxopyrido[1,2-a]pyrimidin-3-yl]methylidene]-2-sulfanylidene-1,3-thiazolidin-4-one |
| MolecularFormula | C25H20N4O4S2 |
| Smiles | OC(CNC(N=C1N2C=CC=C1)=C(/C=C(/C(N1Cc3ccco3)=O)\SC1=S)C2=O)c1ccccc1 |
| InChI | InChI=1S/C25H20N4O4S2/c30-19(16-7-2-1-3-8-16)14-26-22-18(23(31)28-11-5-4-10-21(28)27-22)13-20-24(32)29(25(34)35-20)15-17-9-6-12-33-17/h1-13,19,26,30H,14-15H2/t19-/m0/s1 |
| InChIK | NSENLBKHVGWLHW-IBGZPJMESA-N |
| TotalMolweight | 504.59 |
| Molweight | 504.59 |
| MonoisotopicMass | 504.092596 |
| CLogP | 0.6497 |
| CLogS | -5.344 |
| H Acceptors | 8 |
| H Donors | 2 |
| TotalSurfaceArea | 369.94 |
| Relative PSA | 0.3483 |
| PolarSurfaceArea | 155.77 |
| Druglikeness | 6.5624 |
| Mutagenic | none |
| Tumorigenic | none |
| Reproductive Effective | none |
| Irritant | none |
| Nasty Functions | polar activated DB |
| Shape Index | 0.48571 |
| Fragments | 1 |
| Non HAtoms | 35 |
| NonCHAtoms | 10 |
| Electronegative Atoms | 10 |
| StereoCenters | 1 |
| Rotatable Bond | 7 |
| Rings Closures | 5 |
| Small Rings | 5 |
| Aromatic Rings | 2 |
| Aromatic Atoms | 11 |
| Sp3Atoms | 6 |
| Symmetricatoms | 2 |
| Amides | 2 |
| BasicNitrogens | 1 |
| StereoCon | racemate |
Click to Load Molecule:
1 - (5Z)-3-(furan-2-ylmethyl)-5-[[2-[(2-hydroxy-2-phenylethyl)amino]-4-oxopyrido[1,2-a]pyrimidin-3-yl]methylidene]-2-sulfanylidene-1,3-thiazolidin-4-one | 2 - (5Z)-3-(furan-2-ylmethyl)-5-[[2-[(2-hydroxy-2-phenylethyl)amino]-4-oxopyrido[1,2-a]pyrimidin-3-yl]methylidene]-2-sulfanylidene-1,3-thiazolidin-4-one